In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Panel Not Changing Its Mind About Parabens Safety, Renewing NGO Accusations Of Bias

This article is powered by The Rose Sheet

Executive Summary

Halfway through the Cosmetic Ingredient Review Expert Panel’s September 24-25 meeting, Women’s Voices for the Earth was already blogging that the panel seemed set on declaring parabens safe (which it went on to do on a tentative basis) despite what the NGO sees as increasing evidence to the contrary. Panelist statements from previous meetings suggest a pro-industry agenda, WVE suggests.

You may also be interested in...



CIR ‘Watchdog’ Women’s Voices For The Earth To Remain On Guard In 2021

NGO says the Expert Panel for Cosmetic Ingredient Safety’s conclusion on methylisothiazolinone in 2020 was among decisions “not in the interest of public health.” However, other assessments highlighted by the group suggest that the Cosmetic Ingredient Review is working as an open forum for public input and discussion.

COVID-19 Pandemic: ‘Clean Beauty’ Disruptor Or Reinforcer?

Marketing intelligence firms have different ideas about how the COVID-19 pandemic will impact the “clean beauty" phenomenon.

CIR Expert Panel Finds MCI/MI Preservative Combo Safe With Caveats

CHART: At their December meeting, the Cosmetic Ingredient Review’s toxicology experts finalized four ingredient reports and issued five tentative safety assessments, plus four insufficient data announcements. The Expert Panel’s MCI/MI decision essentially upholds its 1992 stance on the preservative mixture, while highlighting its sensitization potential.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121857

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel